| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $422.8M | — | -11.6% |
| Cost of Revenue | $261.8M | — | -8.7% |
| Gross Profit | $161.0M | — | -16.0% |
| R&D Expense | $13.8M | — | -0.7% |
| SG&A Expense | $102.4M | — | -0.5% |
| Operating Income | -$18.9M | — | -193.1% |
| Interest Expense | $19.3M | — | +2.7% |
| Pre-tax Income | -$36.9M | — | -2070.6% |
| Income Tax | -$7.7M | — | -2025.0% |
| Net Income | -$65.7M | — | -3028.6% |
| EPS (Basic) | -$1.41 | — | -3425.0% |
| EPS (Diluted) | -$1.41 | — | -3425.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $154.0M | +11.8% | +27.8% |
| Inventory | $461.2M | -4.8% | -8.1% |
| Current Assets | $1.06B | +6.2% | +11.8% |
| Total Assets | $3.77B | +0.3% | +1.8% |
| Current Liabilities | $497.5M | -12.0% | +8.4% |
| Long-term Debt | $1.53B | +9.9% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$125.9M | — | -8.9% |
| Investing Cash Flow | -$9.9M | — | +36.9% |
| Financing Cash Flow | $133.4M | — | +21.4% |
| +5.4% |
| Total Liabilities | $2.28B | +3.6% | +3.6% |
| Stockholders' Equity | $1.49B | -4.3% | -1.0% |